Cold News and Research

RSS

Clinical trial of novel rabies vaccine in human volunteers begins in Tanzania

The University of Oxford and the Ifakara Health Institute today announced the vaccination of the first participants in a Phase Ib/II trial testing a novel rabies vaccine in human volunteers in Tanzania.

9 Mar 2022

Study suggests recent common cold may actually lead to worse COVID-19 disease

A new study published in the Journal of Infectious Diseases shines an unexpected light on the notion that pre-existing immunity to common cold coronaviruses can protect us from coronavirus disease 2019 (COVID-19) – and reveals that this may actually put certain individuals at risk of more severe clinical presentations.

8 Mar 2022

Utilizing UV direct irradiation to combat airborne pathogens such as SARS-CoV-2

Researchers describe a method to safely sanitize an occupied room using ultraviolet (UV)-C radiation.

8 Mar 2022

Third-party physicians prescribe more antibiotics through telehealth than hospital-affiliated doctors

During the COVID-19 pandemic, the demand for telemedicine boomed – increasing 63-fold among Medicare users alone from approximately 840,000 telehealth visits in 2019 to 52.7 million in 2020.

8 Mar 2022

Study identifies new immune checkpoint that may be exploited for cancer treatment

A collaborative study led by the Monash Biomedicine Discovery Institute has discovered a new immune checkpoint that may be exploited for cancer therapy.

8 Mar 2022

Rising global temperatures likely to increase the health burden from hyponatremia

Global warming is likely to increase the number of people requiring hospitalization due to critically low sodium levels in the blood, a condition known as hyponatremia.

8 Mar 2022

Thermostable next-generation vaccine candidate against SARS-CoV-2 variants of concern studied in mice

Researchers developed a highly thermo-tolerant vaccine candidate that elicited high nAb titers in mice against several SARS-CoV-2 variants of concerns.

8 Mar 2022

The NFL has been using an unproven measure to get players with covid back on the field fast

Two months before the Super Bowl, the omicron surge was decimating NFL rosters as players tested positive for covid-19. In mid-December, the NFL postponed a game between the Los Angeles Rams and the Seattle Seahawks because the Rams, who would go on to win the Super Bowl, had 29 players out with covid.

8 Mar 2022

Flow Eighteen38 receives €5 million EUR (c.$5.58 million USD) to expand production and biophysical capabilities

Flow Eighteen38, a protein sciences division created to facilitate and accelerate antibody characterization and protein purification projects, today announced a €5 million EUR (c.$5.58 million USD) investment into its protein production and biophysical characterization capabilities and services from its parent company, FairJourney Biologics S.A. (FJB), leaders in the discovery and optimization of antibodies.

From FairJourney Biologics S.A. 8 Mar 2022

Current progress in SARS-CoV-2 vaccine candidates

In a new study, researchers illustrated the current progress and obstacles in COVID-19 vaccine development.

7 Mar 2022

Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses

Scientists have recently revealed that memory T cell responses to common cold coronaviruses stably persist for a long time.

4 Mar 2022

Resistance exercises may be a new way to promote better sleep and improve heart health

Resistance exercise may be superior to aerobic exercise as a way to get better sleep, and sleep is important for cardiovascular health, according to preliminary research to be presented at the American Heart Association's Epidemiology, Prevention, Lifestyle & Cardiometabolic Health Conference 2022.

3 Mar 2022

To be one in a million: ‘Who thinks it’s going to be you?’

Monica Melkonian wanted the Johnson & Johnson covid vaccine. It was only one shot and then she would be protected against the virus. So she was thrilled when the vaccination clinic at the Deschutes County Fair & Expo Center on April 7 had her first choice.

2 Mar 2022

The prevalence of SARS-CoV-2 in environment and animal samples from the Huanan seafood market

A new study describes the surveillance of SARS-CoV-2 within the Huanan seafood market.

2 Mar 2022

Study identifies olfactory dysfunction as an early symptom of COVID-19

In a new study, scientists researched olfactory loss and dysfunction among COVID-19 patients to objectively characterize it as a symptom of COVID-19.

1 Mar 2022

Treatment with Tumor Treating Fields triggers downstream anti-tumor cell response, study finds

Novocure announced that a new study published in the Journal of Clinical Investigation (JCI) finds treatment with Tumor Treating Fields (TTFields) mediated cell disruption activates the immune system and triggers an anti-tumor cell response that may be effectively used together with existing immunotherapy approaches in the treatment of solid tumors, with limited systemic toxicity.

25 Feb 2022

Cold News and Research

Clinical trial of novel rabies vaccine in human volunteers begins in Tanzania

Study suggests recent common cold may actually lead to worse COVID-19 disease

Utilizing UV direct irradiation to combat airborne pathogens such as SARS-CoV-2

Third-party physicians prescribe more antibiotics through telehealth than hospital-affiliated doctors

Study identifies new immune checkpoint that may be exploited for cancer treatment

Rising global temperatures likely to increase the health burden from hyponatremia

Thermostable next-generation vaccine candidate against SARS-CoV-2 variants of concern studied in mice

The NFL has been using an unproven measure to get players with covid back on the field fast

Flow Eighteen38 receives €5 million EUR (c.$5.58 million USD) to expand production and biophysical capabilities

Current progress in SARS-CoV-2 vaccine candidates

Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses

Resistance exercises may be a new way to promote better sleep and improve heart health

To be one in a million: ‘Who thinks it’s going to be you?’

The prevalence of SARS-CoV-2 in environment and animal samples from the Huanan seafood market

Study identifies olfactory dysfunction as an early symptom of COVID-19

Treatment with Tumor Treating Fields triggers downstream anti-tumor cell response, study finds

A comparison of COVID-19 vaccines by neutralizing antibody potency

Immunomolecular detection method to rapidly and accurately detect complete SARS-CoV-2 virions

Why pregnant people were left behind while vaccines moved at ‘warp speed’ to help the masses

Climate change is sickening, literally!

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News